{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:03:56Z","timestamp":1794639836622,"version":"4.9.1"},"reference-count":38,"publisher":"FapUNIFESP (SciELO)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1590\/s0100-879x2011007500140","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T04:29:16Z","timestamp":1318652956000},"page":"1134-1140","source":"Crossref","is-referenced-by-count":12,"title":["Effect of TNF-\u03b1 production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals"],"prefix":"10.1590","volume":"44","author":[{"given":"T.","family":"Luna","sequence":"first","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Santos","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.F.","family":"Porto","sequence":"additional","affiliation":[{"name":"Universidade Federal de Sergipe, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Muniz","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia, Brasil; Instituto Nacional de Ci\u00eancia e Tecnologia de Doen\u00e7as Tropicais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Jesus","sequence":"additional","affiliation":[{"name":"Universidade Federal de Sergipe, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"959","article-title":"Seroepidemiology of human T-cell lymphotropic virus type I\/II in northeastern Brazil","volume":"6","author":"Moreira ED Jr","year":"1993","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200312150-00013","article-title":"HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics","volume":"34","author":"Dourado I","year":"2003","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1537-2995.1997.37297203532.x","article-title":"Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study","volume":"37","author":"Galvao-Castro B","year":"1997","journal-title":"Transfusion","ISSN":"https:\/\/id.crossref.org\/issn\/0041-1132","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","article-title":"Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection","volume":"161","author":"Kubota R","year":"1998","journal-title":"J Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-5728(89)90037-4","article-title":"In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM)","volume":"23","author":"Ijichi S","year":"1989","journal-title":"J Neuroimmunol","ISSN":"https:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers","volume":"4","author":"Santos SB","year":"2004","journal-title":"BMC Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13550280260422668","article-title":"Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP)","volume":"8","author":"Osame M","year":"2002","journal-title":"J Neurovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1355-0284","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410290214","article-title":"Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study","volume":"29","author":"Kira J","year":"1991","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai M","year":"1998","journal-title":"J Neurovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1355-0284","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","article-title":"Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"97","author":"Nishimoto N","year":"1990","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200105010-00001","article-title":"Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors","volume":"27","author":"Carvalho EM","year":"2001","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/aid.2006.0140","article-title":"Clinical manifestations associated with HTLV type I infection: a cross-sectional study","volume":"23","author":"Caskey MF","year":"2007","journal-title":"AIDS Res Hum Retroviruses","ISSN":"https:\/\/id.crossref.org\/issn\/0889-2229","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.ijir.3901335","article-title":"Erectile dysfunction and HTLV-I infection: a silent problem","volume":"17","author":"Castro N","year":"2005","journal-title":"Int J Impot Res","ISSN":"https:\/\/id.crossref.org\/issn\/0955-9930","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/gast.2002.33426","article-title":"Biologic therapy of inflammatory bowel disease","volume":"122","author":"Sandborn WJ","year":"2002","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor: biology and therapeutic inhibitors","volume":"119","author":"Papadakis KA","year":"2000","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa HA","year":"2001","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref17","first-page":"13","article-title":"Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M","volume":"56","author":"Sampaio EP","year":"2002","journal-title":"leprae-induced TNFalpha production in vitro. Biomed Pharmacother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1568-9972(03)00048-X","article-title":"The biology of TNF blockade","volume":"2","author":"Suryaprasad AG","year":"2003","journal-title":"Autoimmun Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.1997.00435.x","article-title":"Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes","volume":"90","author":"Neuner P","year":"1997","journal-title":"Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0019-2805","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-510X(96)05337-3","article-title":"The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM)","volume":"148","author":"Hatae T","year":"1997","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0167-5699(99)01531-5","article-title":"Thalidomide as an emerging immunotherapeutic agent","volume":"20","author":"Marriott JB","year":"1999","journal-title":"Immunol Today","ISSN":"https:\/\/id.crossref.org\/issn\/0167-5699","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke JF","year":"1983","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain A","year":"1985","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame M","year":"1986","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0167-5699(97)01118-3","article-title":"Taming TNF: strategies to restrain this proinflammatory cytokine","volume":"18","author":"Eigler A","year":"1997","journal-title":"Immunol Today","ISSN":"https:\/\/id.crossref.org\/issn\/0167-5699","issn-type":"print"},{"key":"ref26","first-page":"117","article-title":"[Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study]","volume":"12","author":"de Carsalade GY","year":"2003","journal-title":"Acta Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0001-5938","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2249.1998.00510.x","article-title":"Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL)","volume":"111","author":"Sampaio EP","year":"1998","journal-title":"Clin Exp Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado PR","year":"2007","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.intimp.2008.03.020","article-title":"Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections","volume":"8","author":"Ribeiro de Jesus A","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-4632.2006.02867.x","article-title":"Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis","volume":"45","author":"Sadeghian G","year":"2006","journal-title":"Int J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0011-9059","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"5","author":"Hermine O","year":"2004","journal-title":"Hematol J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/344269","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease","volume":"186","author":"Jacobson S","year":"2002","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000097259","article-title":"Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1","volume":"13","author":"Santos SB","year":"2006","journal-title":"Neuroimmunomodulation","ISSN":"https:\/\/id.crossref.org\/issn\/1021-7401","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI23913","article-title":"Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease","volume":"115","author":"Yamano Y","year":"2005","journal-title":"J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9343(03)00390-5","article-title":"Autoimmune aspects of cytokine and anticytokine therapies","volume":"115","author":"Krause I","year":"2003","journal-title":"Am J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-5728(95)00176-X","article-title":"Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis","volume":"64","author":"Rieckmann P","year":"1996","journal-title":"J Neuroimmunol","ISSN":"https:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-510X(97)00074-9","article-title":"Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy","volume":"151","author":"Shirabe S","year":"1997","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-5728(96)00198-1","article-title":"Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy","volume":"73","author":"Tsujino A","year":"1997","journal-title":"J Neuroimmunol","ISSN":"https:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v44n11\/478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:31:46Z","timestamp":1686389506000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2011001100009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0100-879X2011001100009"],"URL":"https:\/\/doi.org\/10.1590\/s0100-879x2011007500140","relation":{},"ISSN":["0100-879X"],"issn-type":[{"value":"0100-879X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}